跳至主要内容
临床试验/NCT07098234
NCT07098234已完成不适用

Determination of the Effect of Vitamin-D as an Adjuvant to Phototherapy in Reduction of Indirect Serum Bilirubin Among Neonates With Exaggerated Physiological Hyperbilirubinemia.

Muhammad Aamir Latif1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2022年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Bilirubin reduction comparison

研究概览

简要总结

The study aimed at filling the gaps by evaluating the effectiveness of vitamin-D as an adjuvant to phototherapy in reduction of indirect serum bilirubin among neonates with exaggerated physiological hyperbilirubinemia.

详细描述

If vitamin-D has been found effective as an adjuvant to phototherapy in the treatment of exaggerated physiological hyperbilirubinemia, it may help to reduce the serum bilirubin level rapidly. It may also reduce the complications by shortening the duration of phototherapy to offer better patient compliance and better patient outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Days 至 8 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Newborns of any gender
  • Age of 3rd day of life to 8th day of life
  • Gestation age ≥37 to ≤42 weeks
  • Total serum bilirubin level more than 12.9 mg/dL
  • Weight > 2.5 kg

排除标准

  • Congenital defects (on physical examination)
  • Large for gestational age infant
  • Rh Incompatibility (were excluded on basis of blood grouping of mother and baby)
  • ABO Incompatibility (were excluded on basis of blood grouping of mother and baby)
  • Neonatal sepsis

研究组 & 干预措施

Vitamin D3 group

Experimental

Neonates were given vitamin D3 (cholecalciferol) in an oral drops formulation (400 IU/drop), at a dose of 400 IU once a day for 72 hours as an adjuvant therapy to phototherapy.

干预措施: Vitamin D3 (Drug)

Vitamin D3 group

Experimental

Neonates were given vitamin D3 (cholecalciferol) in an oral drops formulation (400 IU/drop), at a dose of 400 IU once a day for 72 hours as an adjuvant therapy to phototherapy.

干预措施: Phototherapy (Procedure)

Phototherapy group

Experimental

Neonates received only phototherapy for 72 hours.

干预措施: Phototherapy (Procedure)

结局指标

主要结局

Bilirubin reduction comparison

时间窗: 72 hours

Net reductions in bilirubin levels in two groups after 72 hours were compared.

次要结局

未报告次要终点

研究者

发起方
Muhammad Aamir Latif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (1)

Loading locations...

相似试验